-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Vaxcyte, Maintains $89 Price Target

Benzinga·10/05/2026 17:39:33
Listen to the news
BTIG analyst Thomas Shrader reiterates Vaxcyte (NASDAQ:PCVX) with a Buy and maintains $89 price target.